Navigation Links
AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
Date:5/15/2008

QUEBEC CITY, May 15 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Financial Officer, Dennis Turpin, CA, will present a company overview at the upcoming Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 9:40 am (local time), in the Atlantique Salon - Meridional (2nd floor) of the Meridien Beach Plaza Hotel at the Sea Club, in Monaco.

A live webcast of this presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

Also on Tuesday, May 20, 2008, Professor, Jurgen Engel, Ph.D., Executive Vice President and Chief Scientific Officer at AEterna Zentaris will make a poster presentation at the American Urological Association's Annual Meeting, from 10:30 am to 12:30 pm (Eastern Time) in Room 315 AB of the Orange County Convention Center in Orlando, Florida. Titled, "Luteinizing Hormone-Releasing Hormone (LHRH) Receptors in BPH as Potential Molecular Targets for Therapy with Cetrorelix", the presentation will focus on the Company's lead compound, cetrorelix, which could provide rapid and long lasting improvement of symptoms in men with benign prostatic hyperplasia.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
2. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
3. AEterna Zentaris to Announce First Quarter 2008 Financial and Operating Results and Hold Annual Shareholder Meeting on May 7, 2008
4. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
5. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
6. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
7. AEterna Zentaris Announces Changes to its Management Team
8. AEterna Zentaris and Paladin Labs Complete Sale and Purchase of Miltefosine Rights
9. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2
...by the economic indicators alone, you might conclu...e dusty, bypassed town in the hit animated movie C...Hollywood ending, maybe theres a more prosperous, ..., ,Lets hope so, because without a healthy Milwau...ecent spate of statistics confirms what most obser...
...Medica , a supplier of medical informatics technol...rcore clinical information manager at the communit... installation began in March 2006 and, according t...s for a month. , ,The Evercore system integrates ...EKG, MRI, and ultrasound, and makes the images of ...
...automated anti-money laundering application capabl...transactions is helping banks comply with federal ...ve to support clients working to comply with regul...t Act and the Bank Secrecy Act (BSA), the Milwauk... subsidiary of Marshall & Ilsley Corp , recently ...
Other Biology Technology:It's an economic fact: As Milwaukee goes, so goes Wisconsin 2It's an economic fact: As Milwaukee goes, so goes Wisconsin 3Metavante application aimed at compliance 2
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Uninsured Issue Takes Center Stage This Weekend in New Orleans 61155 1Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 1Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 1China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 3
... Minnesota Medical School and Brain Sciences Cente...fied a noninvasive and painless way to diagnose co... at a point of light., The research offers promise...gnosis for brain diseases, as well as a way to mea... these diseases.,Using magnetoencephalography (MEG...
...al Society (ACS) News Service Weekly Press Package...rom scientific presentations scheduled for the ACS...erage of reports from ACS 36 major peer-reviewed j...e with the Aug. 29, 2007 edition. , , ACS NEWS ...OR VARIOUS TIMES AS INDICATED , PressPac Archive:...
...r, younger looking skin, scientists from the Unive...ave made an important discovery toward manipulatin...search range from helping doctors develop more nat...cosmetics companies develop new products for achie...published in the September print issue of The FASE...
Other Biology News:U of MN researchers discover noninvasive diagnostic tool for brain diseases 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 3American Chemical Society's Weekly PressPac -- Aug. 15, 2007 4American Chemical Society's Weekly PressPac -- Aug. 15, 2007 5American Chemical Society's Weekly PressPac -- Aug. 15, 2007 6American Chemical Society's Weekly PressPac -- Aug. 15, 2007 7American Chemical Society's Weekly PressPac -- Aug. 15, 2007 8American Chemical Society's Weekly PressPac -- Aug. 15, 2007 9American Chemical Society's Weekly PressPac -- Aug. 15, 2007 10American Chemical Society's Weekly PressPac -- Aug. 15, 2007 11American Chemical Society's Weekly PressPac -- Aug. 15, 2007 12American Chemical Society's Weekly PressPac -- Aug. 15, 2007 13Scientists discover important beauty secret for balanced skin color and tone 2
Mouse Anti-Human Procollagen Type I C-Peptide (PIP) Monoclonal Antibody, Unconjugated, Clone PC5-5 from QED Bioscience Inc.
Microcystin-Agarose from Upstate
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Bcl-G, C-Terminus Polyclonal Antibody, Unconjugated from AnaSpec
Biology Products: